
    
      Patients will receive 4 to 8 cycles of chemotherapy according to Institutional guidelines.
      Triptorelin 3.75 will be administered as an intramuscular injection before chemotherapy and
      every 28 days thereafter for all the duration of chemotherapy in patients with ER negative
      tumors and for 2 to 5 years in patients with ER positive tumors according to Institutional
      guidelines. Patients with ER+ve tumour will receive tamoxifen for 5 years at the end of
      chemotherapy as standard care. A blood sample will be drawn after signed informed consent to
      determine baseline AMH levels. A blood sample for determination of AMH levels will be
      collected at the end of chemotherapy and at 12 months after the end of chemotherapy.
    
  